Keywords: Novo Nordisk, Taiwan university, NCKU, Osteoporosis, Rheumatoid arthritis, Technology

Novo Nordisk to acquire Taiwanese osteo/RA technology

Article | 17 May 2012

Print This

Danish insulin giant Novo Nordisk (NOV: N) has acquired rights to technology developed by a southern Taiwan-based National Cheng Kung ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in